1. (valid email required)
 

cforms contact form by delicious:days

Archive for April, 2010

Armin Molavi Joins One to One Interactive

As SVP of Marketing Services Will Lead Engagement with Growing List of Fortune 500 Clients

Boston, Mass. April 5, 2010 – One to One Interactive, Inc. (OTO), a Boston-based digital marketing firm, announced today that Armin Molavi will be joining the firm as Senior Vice President of Marketing Services for their digital marketing agency division, OTOi.

Armin comes to OTOi from Publicis Groupe’s Digitas, where he most recently led the P&G Oral Care business, including Crest, Oral-B and Crest Whitestrips.  In this position, Armin was responsible for managing the digital marketing efforts for all Global campaigns which included, winning Agency of Record in Latin America, EMEA and Greater China.  His other clients at Digitas include General Motors, Bank of America and Allstate, among others.

Prior to Digitas, Armin spent time at Arnold Worldwide where he led the digital efforts for both RadioShack and Progressive Insurance, both of which were fully integrated relationships at the Boston-based Havas shop.

In his new role, Armin will be responsible for leading strategy and execution related to search engine marketing, social media,display media and CRM.  He will also be working on developing new services and offerings, and will participate in One to One’s expanding thought leadership practices.

“One to One has a truly unique vision for what a digital marketing firm should be as the space continues to evolve,” said Armin, “and I’m truly excited to be a part of bringing it to life.  OTO is combining its rich heritage in digital direct marketing with cutting-edge strategies and services to add to its track record of successful results for clients.”

Cindy Starr, Executive Vice President and General Manager of OTOi, said of Armin, “We’re thrilled to have Armin join the executive team at One to One Interactive. Armin brings a wealth of relevant experience that will help to support our continued expansion in key verticals as well as our international growth.”

About One to One Interactive

Complete One-To-One Solutions for Brands, Agencies, and Publishers

Established in 1997, One to One Interactive is the first enterprise to assemble a complete solution for brands, agencies, and publishers executing one-to-one marketing strategies. By bringing together one of the nation’s leading digital marketing agencies, the worlds most comprehensive portfolio of permission marketing platforms, performance marketing solutions, and cutting edge customer experience research techniques, the companies of One to One Interactive build informed and creative customer/constituent strategies on the belief that digital media’s ability to enable engaging one-to-one dialogues is the future of marketing.

One to One Interactive has recently been ranked by Inc. Magazine as one of the fastest growing private companies in America, one of the Top Interactive firms in the United States according to B2B Magazine, and one of the world’s 20 hottest independent digital marketing firms by Ad Age.

One to One Interactive’s web sites for more information:

Armin Molavi Joins One to One Interactive
One to One Interactive, Inc. (OTO), a Boston-based digital marketing firm, announced today that Armin Molavi will be joining the firm as Senior Vice President of Marketing Services for their digital marketing agency division, OTOi. »

Curaspan Customers Cut Preventable Readmission Rates and Save Almost $180 Million in One Year

Electronic Data Capture, Analysis and Response Could Help U.S. Hospitals Reduce Readmissions, Saving More Than $7.3 Billion Annually

NEWTON, Mass. — March 24, 2010 — Acute-care facilities that regularly review and respond to data about trends in readmissions can substantially lower readmission rates and save, on average, $1.3 million per year, according to Curaspan Health Group, the industry leader in building secure electronic patient-transition networks for hospitals, post-acute providers and suppliers.

A review of aggregated 2009 data for 137 hospitals, most with more than 150 beds, reveals that hospitals regularly reviewing monthly reports with detailed readmissions-related data are reducing their preventable readmission rates by an average of 0.5 percent. That translates into approximately $108,000 per month or nearly $1.3 million annually per hospital, based on 15 fewer readmissions each month at an average case rate of $7,200.

“Regularly receiving, reviewing and responding to data pays off,” says Carol Everhart, RN, BA, director of clinical informatics at Curaspan. “Our trending data shows that after about six months of data usage, hospitals start cutting their readmission rates. They discover a trend, identify the root cause or causes behind it and then implement a plan to address it that improves patient care.”

Readmissions reports are part of the portfolio of best-practices reports generated for hospitals by the Curaspan eDischargeTM software-as-a-service application, which provides hospitals with business intelligence for better decision-making and quantifiable results.

“Institutionalize more data discipline, and the lower costs and improved care from fewer readmissions nationwide could translate into more than $7.3 billion in savings,” continues Everhart. “Even if just half of the other hospitals in the U.S. adopted the same approach, a few billion dollars could be cut from health-care costs and hundreds of thousands of patients saved from a return trip to the hospital.”

At Franklin Square Hospital Center (FSHC) in Baltimore, Director of Case Management Jan Lear, RN, CMC, relies heavily on Curaspan data. The Curaspan Clinical Data BankTM, says Lear, is “the only source that tells me which facilities or home health-services are generating the most readmissions.”

Reports in the Curaspan Clinical Intelligence Data Bank make it easy to track readmissions by post-acute provider, placement, diagnosis and physician. Whether reports are updated monthly or weekly, they enable hospitals to identify performance-improvement initiatives that have a positive impact on the transition of care and, by extension, the bottom line.

Lear and her staff are using the reports with post-acute partners to track readmissions by facility for congestive heart failure and chronic obstructive pulmonary disease, two of the primary reasons for readmissions to FSHC, and to develop protocols for improved outcomes.

Just updated with a more modern and cohesive style which makes them even more user-friendly and easy to interpret, the reports are available in Crystal Reports, Excel and PDF and capture actionable patient-transition data on a wide range of topics. From readmission rates and average LOS to provider performance and network leakage, the Curaspan Clinical Intelligence Data Bank empowers hospital and post-acute provider staff to do more of what they do, better.

For more information about using the Curaspan Clinical Data Bank to cut preventable readmissions, join Carol Everhart, director of clinical informatics, for a webinar April 15 at 2 p.m. EDT.

Curaspan HIPAA-compliant software — built with clinical expertise from case managers, discharge planners and social workers — is easy to deploy and use and requires less than three hours of training. Over the past year, it has helped facilitate the smooth transition of almost 600,000 patients on behalf of hundreds of hospitals across the country. Curaspan works with many of the nation’s top hospital and post-acute care providers, including Johns Hopkins Health System, New York Presbyterian, St. Thomas Health Services (part of Ascension Health), Vanguard Health Systems, Amedisys Home Health Services, American Medical Response, Gentiva Health Services, Golden LivingCenters, Kindred Healthcare, Life Care Centers of America and Sunbridge Health, among many others.

About Curaspan Health Group

Curaspan Health Group builds secure patient-transition networks for hospitals, post-acute providers and suppliers to optimize patient care. Curaspan software-as-a-service (SaaS) applications empower users with real-time, predictive decision-making data that enables all participants to continuously monitor care, improve communication and ensure compliance. This informatics exchange is integrated with the proprietary Curaspan Provider Data Bank, the industry’s most comprehensive and up-to-date system of actionable patient-transition intelligence, and is complemented by the clinical process expertise of credentialed advisors. The Health Care Advisory Board and KLAS repeatedly have recognized Curaspan for its industry-leading software. Curaspan is headquartered in Newton, Mass. For more information please visit Curaspan.com.

Media Contact:
Sarah Mees
KMC Partners Public Relations
978-208-1499

Sarah@KMCPartners.com

Curaspan Customers Cut Preventable Readmission Rates and Save Almost $180 Million in One Year
Acute-care facilities that regularly review and respond to data about trends in readmissions can substantially lower readmission rates and save, on average, $1.3 million per year, according to Curaspan Health Group, the industry leader in building secure electronic patient-transition networks for hospitals, post-acute providers and suppliers. »

CRi Announces Strategic Partnership with 3DHISTECH

Partnership to expand industry adoption of digital imaging and analysis

Woburn, Massachusetts – March 22, 2010- Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH’s full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi’s offerings in the rapidly growing digital pathology market.

“3DHISTECH’s superior slide scanning and analysis products are a clear fit with CRi’s focus on providing pathologists and researchers with the right tools to generate more in-depth and reliable information from tissue slides,” said George Abe, CRi’s president and CEO. “Digital pathology, to create, analyze, and manage digital images of glass microscope slides, has become an important approach to enhancing the quality and efficiency of pathology laboratory workflow. 3DHISTECH has developed an outstanding set of digital pathology products for the market.”

Abe added that digital pathology technologies are providing important infrastructure for emerging molecular diagnostic approaches based on disease-related biomarkers that CRi is also advancing with its optical imaging and analysis systems. CRi’s core technologies are transforming anatomic pathology from a morphology to a molecular-driven discipline.

3DHISTECH offers a broad line of digital pathology products, software and services, including high resolution, high throughput scanners, and software for slide viewing, quantitation, telemedicine, and image management. The company has built a leading position in digital pathology in Europe.

“The partnership with CRi will accelerate our growth throughout North America,” said Dr. Belá Molnár, CEO and founder of 3DHISTECH. “CRi’s market presence and reputation for quality provide a great complement to our product line, and its tissue imaging systems, which uniquely quantitate multiple biomarkers, provide many opportunities for synergies. Both companies are excited to announce this partnership coincident with the launch of new and improved 3DHISTECH scanner and software products for the North American market, and believe it is especially appropriate that our customers get a first look at these products at the prestigious 2010 USCAP Conference in Washington, DC.”

About 3DHISTECH

3DHISTECH Kft is based in Budapest, Hungary. With a significant knowledge base, the company is not only adapting to the extremely fast changing field of digital pathology but it is at the forefront of technical innovation. The company began developing whole slide imaging ten years ago before it had achieved widespread acceptance and adoption. Now, the concept of digital slides has become a reality, providing solutions to the bottlenecks in a modern pathology lab.

Learn more at: http://www.3dhistech.com

About CRi

Cambridge Research & Instrumentation, Inc. (CRi) develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented systems enable researchers and clinicians to quantitate multiple disease and drug response markers in intact tissue samples, at a cellular level or in living small animals. CRi’s products integrate a unique multispectral imaging technology with proprietary image analysis algorithms to achieve unparalleled accuracy and sensitivity, rapidly and cost-effectively. CRi’s award-winning systems include Nuance™ for multispectral imaging on brightfield and fluorescence microscopes; inForm™ automated image analysis software; Vectra™ for high-throughput slide imaging and analysis; and Maestro™ for in-vivo optical imaging. Learn more at www.cri-inc.com.

For more information, contact:

Cambridge Research & Instrumentation, Inc. (CRi)

Cathy Boutin, 781-935-9099

Marketing Manager

cboutin@cri-inc.com

Commonwealth Creative Associates

Jamie Bull, 508-620-0791

Digital Media Strategist

jamieb@commcreative.com

Commonwealth Creative Associates

Donna Phelps, 508-620-0791

Senior Account Executive

donnap@commcreative.com

CRi Announces Strategic Partnership with 3DHISTECH
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH’s full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi’s offerings in the rapidly growing digital pathology market. »

Samsung Total Expects More Than $5M in Annual Savings from Deployment of aspenONE® Planning & Scheduling Software

Korean Petrochemical Company Achieves Better Inventory Visibility and Improves Decision Making at Olefins and Aromatics Plants

Burlington, Mass- March 16th, 2010- Aspen Technology, Inc. (NASDAQ: AZPN), a leading provider of software and services to the process industries, today announced that Samsung Total Petrochemicals Co., Ltd. (Samsung Total) has deployed aspenONE® Planning and Scheduling at its Olefins and Aromatics plants in Daesan, Korea. Based on initial results, Samsung Total expects to achieve $5 million in annual savings by using aspenONE software.

Supporting Quotes:
Mr. Young-In Yoon, VP of Base Chemical Production Business Unit, Samsung Total Petrochemical Co., Ltd
“AspenTech is a trusted partner helping us in this major margin maximization project. AspenTech’s planning and scheduling solution is enabling us to establish tightly integrated planning and scheduling business operations. Based on initial results, we expect to achieve more than $5 million US savings annually, as a result of optimized operations and consequently improved margins.”

Henry Lau, Senior Vice President & Managing Director for APAC, AspenTech
“Satisfied customers such as Samsung Total continue to implement additional modules of the aspenONE suite because they realize good return on investment. AspenTech’s vision is to enable every process company to achieve operational excellence and improve profitability across the enterprise. Our mission is to help customers stay competitive by making manufacturing operations more agile and better able to respond to changing market conditions.”

Supporting Resources
Links to more information:

About Samsung Total Petrochemicals
Samsung Total Petrochemicals (formerly Samsung General Chemicals from 1988 to 2003) was established in August 2003 as a joint venture between the Samsung and the Total Group, a global French energy and chemical company. Samsung Total operates a large petrochemical complex consisting of 15 individual plants located in Daesan, Korea. As a general chemicals company, it manufactures and supplies chemical products for daily life, such as synthetic polymer resins (polyethylene, polypropylene, etc.), base chemicals (styrene monomer, para-xylene, etc.) and other petrochemicals and petroleum-based products. For more information on Samsung Total Petrochemicals, visit www.samsungtotal.com.

About AspenTech
AspenTech is a leading supplier of software that optimizes process manufacturing – for energy, chemicals, pharmaceuticals, engineering and construction, and other industries that manufacture and produce products from a chemical process. With integrated aspenONE solutions, process manufacturers can implement best practices for optimizing their engineering, manufacturing and supply chain operations. As a result, AspenTech customers are better able to increase capacity, improve margins, reduce costs and become more energy efficient. To see how the world’s leading process manufacturers rely on AspenTech to achieve their operational excellence goals, visit www.aspentech.com.

Samsung Total Expects More Than $5M in Annual Savings from Deployment of aspenONE® Planning & Scheduling Software
Aspen Technology, Inc. (NASDAQ: AZPN), a leading provider of software and services to the process industries, today announced that Samsung Total Petrochemicals Co., Ltd. (Samsung Total) has deployed aspenONE® Planning and Scheduling at its Olefins and Aromatics plants in Daesan, Korea. Based on initial results, Samsung Total expects to achieve $5 million in annual savings by using aspenONE software. »

One to One Interactive Acquires fhios

Acquisition Expands OTOinsights Service Offerings in Customer Experience Research

Boston, Mass. and London, UK, February 22, 2010 – One to One Interactive, Inc. (OTO), a Boston-based digital marketing firm recently ranked by Inc. Magazine as one of the fastest growing private companies in America, announced today a definitive agreement to acquire fhios, with operations in the UK, Singapore, and Brazil.

The merger expands One to One Interactive’s comprehensive suite of digital marketing products and services by incorporating fhios’ user experience, research, and design practice with OTOinsights and its patent-pending Neuromarketing research platform, Quantemo.

The move represents the fifth time OTO has grown through a merger or acquisition, a strategy the company embarked on beginning in 2005. The addition of fhios provides OTO with expanded UK/European presence while adding new offices in Brazil and Singapore. fhios has run programs for clients such as Reuters, Motorola, Hilton, eBay, Dell and Philips in industries such as financial services, travel/tourism and media/publishing.

fhios specializes in customer experience strategy, research and design covering areas such as usability, eye tracking, concept testing, brand perception and competitive benchmarking to help answer key business issues to help its clients provide their customers with that all important stellar customer experience.

fhios has a wealth of experience in both public and private sectors in industries ranging from financial services to travel in both B2B and B2C markets. Since 2002, fhios has completed over 400 projects in over 30 countries across multiple channels such as web, mobile, PDA’s, I-TV, call centres, retail outlets and product testing.

“Our acquisition of fhios will help OTO achieve several of it’s 2010 strategic objectives. We are expanding our Web 3.0/semantic customer experience research, design and strategic capabilities at a time when brands are transitioning significant marketing budget from traditional to digital,” said Ian Karnell CEO of One to One Interactive. “Additionally, fhios’ substantial international presence gives OTO access to new markets for all of its products and services.”

“We are excited to become part of One to One Interactive,” said Dr. Philip Rhodes, CEO of fhios who will be the SVP, Managing Director of OTOinsights. “We see this as an opportunity to bring our deep human experience expertise to new North American audience, add OTOinsights neuromarketing research capabilities to our client offerings, and to engage more deeply with our client’s projects.”

About One to One Interactive

Complete One-To-One Solutions for Brands, Agencies, and Publishers Established in 1997, One to One Interactive is the first enterprise to assemble a complete solution for brands, agencies and publishers executing one-to-one marketing strategies. By bringing together one of the nation’s leading digital marketing agencies, the world’s most comprehensive portfolio of permission marketing platforms, performance marketing solutions and cutting-edge neuromarketing research techniques, the companies of One to One Interactive build informed and creative customer/constituent strategies on the belief that digital media’s ability to enable engaging one-to-one dialogues is the future of marketing.

One to One Interactive has recently been ranked by Inc. Magazine as one of the fastest growing private companies in America, one of the Top Interactive firms in the United States according to B2B Magazine, and one of the world’s 20 hottest independent digital marketing firms by Ad Age. Please visit one of One to One Interactive’s web sites for more information:

* One to One Interactive: www.onetooneinteractive.com

* OTOi: www.otoi.com

* OTOlabs: www.otolabs.com

* OTOnetworks: www.otonetworks.com

* OTOinsights: www.otoinsights.com

About fhios

fhios has been a leading international customer experience research consultancy founded in 2002 and has successfully conducted over 400 customer experience and usability research projects across over 35 countries, with many brand perception, customer segmentation, concept & design validation, competitive benchmarking, online communities and user needs projects to provide its clients such as Orange, O2, Samsung, Pay Pal, Motorola, Hilton and Shell/Ferrari with the insight to understand customers needs, goals, expectations, behaviours and experience levels when they engage with them and their competitors.

fhios provides One to One Interactive with operations in London, UK; Sao Paolo, Brazil and Singapore.

For more information, please visit the fhios web site: www.fhios.com or in the UK call +44 (0)207 886 8241.

One to One Interactive Acquires fhios
One to One Interactive, Inc. (OTO), a Boston-based digital marketing firm recently ranked by Inc. Magazine as one of the fastest growing private companies in America, announced today a definitive agreement to acquire fhios, with operations in the UK, Singapore, and Brazil. »

CRi’s Vectra Intelligent Slide Analysis System Wins 2010 Laboratory Equipment Magazine Award

Vectra selected as top “Optics, Cameras, & Image Analyzer”

Woburn, Massachusetts – March 2, 2010- Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, has been chosen as a winner in Laboratory Equipment Magazine’s 2010 Readers Choice Awards. CRi’s Vectra™ Intelligent Slide Analysis System won top honors in the “Optics, Cameras and Image Analyzer” category.

The Readers Choice Award winners are chosen by scientists and engineers who subscribe to Laboratory Equipment, readers who represent the preferences of over 66,000 subscribers of the magazine, which provides news and information on laboratory products, technologies and trends. The winners will be recognized at a reception for leading equipment manufacturers in the laboratory marketplace at Pittcon 2010 in Orlando, Florida on March 2, 2010.

CRi’s Vectra is the world’s only intelligent multispectral fluorescence and brightfield slide analysis system for high-content, high-throughput applications. Vectra’s pattern recognition-based scanning, capable of processing up to 200 slides at a time, provides a more efficient and faster alternative to whole-slide scanning. The period of time to perform a study can be reduced from months to weeks, or even to hours. The Vectra system incorporates CRi’s powerful image analysis software, called inForm™, and CRi’s proprietary multispectral imaging algorithms- providing a powerful tool to extract per-cell multiparameter data similar to that found with flow cytometry, but uniquely maintaining morphological context.

“We are honored to receive this award for The Vectra system,” says CRi President & CEO, George Abe. “This award is verification of CRi’s ability to dramatically impact the speed, quality and reliability of the data collected from any tissue slide.”

About CRi

Cambridge Research & Instrumentation, Inc. (CRi) develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented systems enable researchers and clinicians to quantitate multiple disease and drug response markers in intact tissue samples, at a cellular level or in living small animals. CRi’s products integrate a unique multispectral imaging technology with proprietary image analysis algorithms to achieve unparalleled accuracy and sensitivity, rapidly and cost-effectively. CRi’s award-winning systems include Nuance™ for multispectral imaging on brightfield and fluorescence microscopes; inForm™ automated image analysis software; Vectra™ for high-throughput slide imaging and analysis; and Maestro™ for in-vivo optical imaging. Learn more at www.cri-inc.com.

For more information, contact:

Cambridge Research & Instrumentation, Inc. (CRi)

Cathy Boutin, 781-935-9099

Marketing Manager

cboutin@cri-inc.com

or

Commonwealth Creative Associates

Jamie Bull, 508-620-0791

Digital Media Strategist

jamieb@commcreative.com

or

Commonwealth Creative Associates

Donna Phelps, 508-620-0791

Senior Account Executive

donnap@commcreative.com

CRi’s Vectra Intelligent Slide Analysis System Wins 2010 Laboratory Equipment Magazine Award
Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, has been chosen as a winner in Laboratory Equipment Magazine’s 2010 Readers Choice Awards. CRi’s Vectra™ Intelligent Slide Analysis System won top honors in the “Optics, Cameras and Image Analyzer” category. »

Latest News

Datawatch Self-Service Data Preparation Platform in High Demand in Healthcare Market

NWN Recognized in CRN Elite 150 For Managed IT Services and Placed on Managed Service Provider 500 List

Bigbelly Unveils Top 2016 Successes for Optimized Collections & Recycling Diversion

Southern California Edison Awards Cadmus MSA to Support Zero Net Energy Schools

» More News


Latest Newsletters

April 2017 – MCRC Announces a New Investment in Baynes Electric Supply

March 2017 – Mass Capital Announces a New Investment in Tri-Wire Engineering Solutions, Inc.

July 2016 – Mass Capital Announces a New Investment in The Cadmus Group, Inc.

» More Newsletters


Archives!